- Home
- BGH vs OSUR Comparison
BGH vs OSUR Comparison
Compare BGH & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGH
- OSUR
- Stock Information
- Founded
- BGH 2012
- OSUR 2000
- Country
- BGH United States
- OSUR United States
- Employees
- BGH N/A
- OSUR N/A
- Industry
- BGH Investment Managers
- OSUR Medical/Dental Instruments
- Sector
- BGH Finance
- OSUR Health Care
- Exchange
- BGH Nasdaq
- OSUR Nasdaq
- Market Cap
- BGH 318.2M
- OSUR 289.4M
- IPO Year
- BGH N/A
- OSUR 1986
- Fundamental
- Price
- BGH $15.29
- OSUR $3.64
- Analyst Decision
- BGH
- OSUR Hold
- Analyst Count
- BGH 0
- OSUR 2
- Target Price
- BGH N/A
- OSUR $5.50
- AVG Volume (30 Days)
- BGH 61.5K
- OSUR 1.0M
- Earning Date
- BGH 01-01-0001
- OSUR 11-06-2024
- Dividend Yield
- BGH 10.06%
- OSUR N/A
- EPS Growth
- BGH N/A
- OSUR N/A
- EPS
- BGH N/A
- OSUR 0.15
- Revenue
- BGH N/A
- OSUR $224,263,000.00
- Revenue This Year
- BGH N/A
- OSUR N/A
- Revenue Next Year
- BGH N/A
- OSUR N/A
- P/E Ratio
- BGH N/A
- OSUR $24.10
- Revenue Growth
- BGH N/A
- OSUR N/A
- 52 Week Low
- BGH $11.92
- OSUR $3.61
- 52 Week High
- BGH $14.50
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- BGH 36.06
- OSUR 39.55
- Support Level
- BGH $15.73
- OSUR $3.76
- Resistance Level
- BGH $16.34
- OSUR $4.14
- Average True Range (ATR)
- BGH 0.21
- OSUR 0.17
- MACD
- BGH -0.10
- OSUR -0.01
- Stochastic Oscillator
- BGH 19.38
- OSUR 1.02
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.